BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ACMELAB

All Eps Dividend Board Agm Q1 Q2 Q3

ACMELAB 23-Jan-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2020 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2019.

ACMELAB 07-Nov-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2019 at 3.30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2019.

ACMELAB 10-Oct-2019

The Board of Directors has recommended 35% cash dividend for the year ended on June 30, 2019. Date of AGM: 12.12.2019, Time: 10:30 AM, Venue: PSC Convention Hall, Mirpur-14, Dhaka-1206. Record Date: 31.10.2019. The Company has also reported EPS of Tk. 6.81, NAV per share of Tk. 86.69 and NOCFPS of Tk. 7.81 for the year ended on June 30, 2019 as against Tk. 6.74, Tk. 83.38 and Tk. 7.46 respectively for the same period of the previous year.

ACMELAB 02-Oct-2019

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 09, 2019 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

ACMELAB 02-Jul-2019

The Company has informed that the Board of Directors has declared the commencement of Commercial Production of its state of the art Steroid and Hormone facility at Dulivita, Dhamrai, Dhaka after successful completion of trial production. The Company noted that the aforesaid Steroid and Hormone facility is second of the three projects against which fund was raised through Initial Public Offering (IPO).

ACMELAB 13-Jun-2019

The Company has informed that the Board of Directors has declared the commencement of Commercial Production of its state of the art Penicillin facility at Dulivita, Dhamrai, Dhaka after successful completion of trial production. The Company noted that the aforesaid Penicillin facility is one of the three projects against which fund was raised through Initial Public Offering (IPO).

ACMELAB 24-Apr-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2019 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2019.

ACMELAB 28-Jan-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2019 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2018.

ACMELAB 07-Nov-2018

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2018 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2018.

ACMELAB 03-Oct-2018

The Board of Directors has recommended 35% cash dividend for the year ended on June 30, 2018. Date of AGM: 06.12.2018, Time: 10:30 AM, Venue: PSC Convention Hall, Mirpur-14, Dhaka-1206. Record Date: 31.10.2018. The Company has also reported EPS of Tk. 6.74, NAV per share of Tk. 83.39 and NOCFPS of Tk. 7.46 for the year ended on June 30, 2018 as against Tk. 6.61, Tk. 80.13 and Tk. 6.70 respectively for the same period of the previous year.

Previous Next page